Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)
Q2 2024 Earnings Call
Aug 06, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics Inc. Stock
€0.81
-6.230%
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 8 Buy predictions and 1 Sell predictions.
With a target price of 5 € there is potential for a 519.12% increase which would mean more than doubling the current price of 0.81 € for Karyopharm Therapeutics Inc..